Results 161 to 170 of about 32,411 (197)

Platelets and Thrombolytic Therapy

New England Journal of Medicine, 1990
FIBRINOLYTIC therapy is a major advance in the treatment of occlusive vascular disease. Problems remain, however, including resistance to fibrinolytic therapy, delays in reperfusion, reocclusion after successful thrombolysis, and serious hemorrhage.1 2 3 Increasing evidence indicates that platelets have an important role in both delaying reperfusion ...
openaire   +2 more sources

Thrombolytic therapy in children

Thrombosis Research, 2006
Thrombolysis is increasingly considered a treatment option in newborns and children with arterial and venous thromboembolic events, or occluded central venous lines. However, no uniform recommendations are available with regard to indications, drug of choice, route of administration, and dosing regimen.
openaire   +2 more sources

THROMBOLYTIC THERAPY

British Medical Bulletin, 1978
V V, Kakkar, M F, Scully
openaire   +2 more sources

Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke

Circulation, 2023
Jeffrey Saver, Ken Uchino, Ying Xian
exaly  

Thrombolytic Therapy

Annals of the New York Academy of Sciences, 1991
D, Collen, H R, Lijnen
openaire   +2 more sources

THROMBOLYTIC THERAPY WITH STREPTOKINASE

Medical Journal of Australia, 1970
C N, Chesterman, J C, Biggs
openaire   +5 more sources

Thrombolytic Therapy

New England Journal of Medicine, 1982
Jan Koch-Weser, G. V. R. K. Sharma, Giuseppe Cella, Alfred F. Parisi, Arthur A. Sasahara   +4 more
openaire   +2 more sources

Thrombolytic therapy

American Heart Journal, 1977
openaire   +2 more sources

Thrombolytic Therapy

New England Journal of Medicine, 1981
openaire   +2 more sources

Thrombolytic Therapy for MI

The American Journal of Nursing, 1987
S W, Rodriguez, R L, Reed
openaire   +2 more sources